Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131443
Status:
COMPLETED
Last Update Posted:
2012-11-12
First Post:
2005-08-15
Brief Title:
Dose Comparison Study of Topiramate in Pediatric Subjects With BasilarHemiplegic Migraine
Sponsor:
Monarch Medical Research
Organization:
Monarch Medical Research
Study Overview
Official Title:
A Double-Blind Dose Comparison Study of Topiramate in Pediatric Subjects With BasilarHemiplegic Migraine
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents
Detailed Description:
The objective of this study is to assess the efficacy and safety of topiramate in the prophylaxis of basilar migraine and hemiplegic migraine in children and adolescents by comparing two doses 25 and 100 mgday
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None